Table II.
Evaluation of mean (± standard deviation) concentrations of liver markers in relation to number of metabolic abnormalities used to define metabolic syndrome.
| Liver Marker | Number of Metabolic Abnormalities
|
Trend Test p-value | ||||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | ≥4 | ||
| Men | n = 133 | n = 142 | n = 81 | n = 58 | n = 26 | |
| AST (units/L) | 27.4 ± 22.5 | 27.9 ± 21.2 | 28.7 ± 9.8 | 30.7 ± 11.9 | 35.2 ± 22.1 | 0.059 |
| ALT (units/L) | 27.7 ± 18.6 | 33.6 ± 50.5 | 38.9 ± 22.8 | 44.6 ± 30.2 | 47.6 ± 28.1 | <0.001 |
| AST: ALT ratio | 1.1 ± 0.3 | 1.0 ± 0.4 | 0.9 ± 0.4 | 0.8 ± 0.3 | 0.8 ± 0.2 | <0.001 |
| ALP (units/L) | 66.8 ± 18.0 | 70.1 ± 20.8 | 70.2 ± 18.1 | 74.5 ± 17.4 | 79.6 ± 21.4 | 0.001 |
| Women | n = 427 | n = 261 | n = 130 | n = 68 | n = 32 | |
| AST (units/L) | 21.8 ± 11.0 | 22.1 ± 8.3 | 23.5 ± 8.8 | 23.6 ± 9.0 | 33.8 ± 19.3 | <0.001 |
| ALT (units/L) | 17.4 ± 8.9 | 20.1 ± 15.1 | 23.1 ± 12.6 | 26.8 ± 15.8 | 50.4 ± 41.7 | <0.001 |
| AST: ALT ratio | 1.4 ± 1.0 | 1.3 ± 0.5 | 1.2 ± 0.5 | 1.0 ± 0.3 | 0.8 ± 0.3 | <0.001 |
| ALP (units/L) | 57.6 ± 15.1 | 65.4 ± 18.8 | 68.6 ± 16.8 | 72.7 ± 22.7 | 74.2 ± 16.2 | <0.001 |